Antiphospholipid syndrome

Area of Science:

• Immunology
• Hematology
• Reproductive Medicine

Background:

• Antiphospholipid syndrome (APS) is characterized by thrombosis and/or pregnancy morbidity.
• It is diagnosed by the presence of antiphospholipid antibodies (aPL).
• The precise mechanisms driving APS pathogenesis are still under investigation.

Purpose of the Study:

• To summarize the current understanding of antiphospholipid syndrome (APS).
• To explore the potential role of apoptosis in aPL production.
• To review proposed pathogenic mechanisms and current treatment strategies for APS.

Main Methods:

• Review of existing literature on antiphospholipid syndrome.
• Analysis of proposed etiological factors, including apoptosis and cellular mechanisms.
• Evaluation of current therapeutic approaches and identification of research gaps.

Main Results:

• APS is associated with venous or arterial thromboses and recurrent pregnancy loss.
• Antiphospholipid antibodies (aPL) are key diagnostic markers.
• Potential pathogenic pathways include endothelial activation, lipid peroxidation, and coagulation system dysfunction.

Conclusions:

• The pathogenesis of APS is complex and multifactorial.
• Current treatments, primarily anticoagulation (aspirin, warfarin), have limitations.
• Further research is crucial for developing more effective and safer therapies for APS.